Literature DB >> 24126450

HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.

Allan E Rodríguez1, Amanda D Castel, Carrigan L Parish, Sarah Willis, Daniel J Feaster, Michael Kharfen, Gabriel A Cardenas, Kira Villamizar, Michael Kolber, Liliana Vázquez-Rivera, Lisa R Metsch.   

Abstract

INTRODUCTION: In 2005, the Centers for Disease Control and Prevention expanded its recommendation of postexposure prophylaxis (PEP) use in the workplace to include nonoccupational exposures (nPEP). The availability and extensive use of nPEP have not achieved widespread acceptance among health-care providers of high-risk populations, and public health and primary care agencies have been sparse in their implementation of nPEP promotion, protocols, and practices.
METHODS: We conducted a survey of HIV providers (n = 142, response rate = 61%) in Miami-Dade County (Florida) and the District of Columbia that focused on their knowledge, attitudes, beliefs, and practices related to the delivery of nPEP. We then analyzed differences in survey responses by site and by history of prescribing nPEP using bivariate and multivariate logistic regression.
RESULTS: More District of Columbia providers (59.7%) reported ever prescribing nPEP than in Miami (39.5%, P < 0.048). The majority of practices in both cities did not have a written nPEP protocol and rarely or never had patients request nPEP. Multivariable analysis for history of prescribing nPEP was dominated by having patients request nPEP [odds ratio (OR) = 21.53] and the belief that nPEP would lead to antiretroviral resistance (OR = 0.14) and having a written nPEP protocol (OR = 7.49). DISCUSSION: Our findings are consistent with earlier studies showing the underuse of nPEP as a prevention strategy. The significance of having a written nPEP protocol and of patient requests for nPEP speaks to the importance of using targeted strategies to promote widespread awareness of the use of HIV antiretroviral medications as a prevention intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126450      PMCID: PMC3845443          DOI: 10.1097/QAI.0b013e3182a901a2

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  43 in total

1.  Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.

Authors:  T L Katzenstein; E Dickmeiss; H Aladdin; A Hede; C Nielsen; H Nielsen; L B Jørgensen; J Gerstoft
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

2.  Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006.

Authors:  Andrew C Voetsch; James D Heffelfinger; Elin B Begley; Krishna Jafa-Bhushan; Patrick S Sullivan
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

3.  How many imputations are really needed? Some practical clarifications of multiple imputation theory.

Authors:  John W Graham; Allison E Olchowski; Tamika D Gilreath
Journal:  Prev Sci       Date:  2007-06-05

4.  Survey of nonoccupational HIV postexposure prophylaxis in hospital emergency departments.

Authors:  L M Kunches; T M Meehan; R C Boutwell; J F McGuire
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

5.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

6.  Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Authors:  Jeffrey N Martin; Michelle E Roland; Torsten B Neilands; Melissa R Krone; Joshua D Bamberger; Robert P Kohn; Margaret A Chesney; Karena Franses; James O Kahn; Thomas J Coates; Mitchell H Katz
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

7.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

8.  Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center.

Authors:  Kenneth H Mayer; Matthew J Mimiaga; Daniel Cohen; Chris Grasso; Ronn Bill; Rodney Van Derwarker; Alvan Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-01       Impact factor: 3.731

9.  Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.

Authors:  S D Pinkerton; D R Holtgrave; F R Bloom
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

10.  Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial.

Authors:  Deborah Donnell; Matthew J Mimiaga; Kenneth Mayer; Margaret Chesney; Beryl Koblin; Thomas Coates
Journal:  AIDS Behav       Date:  2010-10
View more
  16 in total

1.  Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2015-01       Impact factor: 5.078

2.  Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County.

Authors:  Matthew R Beymer; Ryan M Kofron; Chi-Hong Tseng; Robert K Bolan; Risa P Flynn; Jennifer M Sayles; Mario J Perez; Wilbert C Jordan; Raphael J Landovitz
Journal:  Int J STD AIDS       Date:  2017-11-29       Impact factor: 1.359

3.  HIV-Related Training and Correlates of Knowledge, HIV Screening and Prescribing of nPEP and PrEP Among Primary Care Providers in Southeast United States, 2017.

Authors:  Kirk D Henny; Christopher C Duke; Angelica Geter; Zaneta Gaul; Chantell Frazier; Jennifer Peterson; Kate Buchacz; Madeline Y Sutton
Journal:  AIDS Behav       Date:  2019-11

4.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

5.  Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group.

Authors:  Alan E Greenberg; Christopher M Gordon; David W Purcell
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

6.  Addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States.

Authors:  Alan E Greenberg; David W Purcell; Christopher M Gordon; Rebecca J Barasky; Carlos del Rio
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

7.  Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.

Authors:  Rudy Patrick; David Forrest; Gabriel Cardenas; Jenevieve Opoku; Manya Magnus; Gregory Phillips; Alan Greenberg; Lisa Metsch; Michael Kharfen; Marlene LaLota; Irene Kuo
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

8.  NIH support of Centers for AIDS Research and Department of Health Collaborative Public Health Research: advancing CDC's Enhanced Comprehensive HIV Prevention Planning project.

Authors:  Alan E Greenberg; David W Purcell; Christopher M Gordon; Stephen Flores; Cynthia Grossman; Holly H Fisher; Rebecca J Barasky
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

9.  "It's Like Plan B but for HIV!" Design and Evaluation of a Media Campaign to Drive Demand for PEP.

Authors:  Jeremy Fagan; Victoria Frye; Rose Calixte; Sachin Jain; Lovely Molla; Adeola Lawal; Marcus P Mosley; Emily Greene; Kenneth H Mayer; Barry S Zingman
Journal:  AIDS Behav       Date:  2020-12

10.  Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP.

Authors:  Amanda D Castel; Daniel J Feaster; Wenze Tang; Sarah Willis; Heather Jordan; Kira Villamizar; Michael Kharfen; Michael A Kolber; Allan Rodriguez; Lisa R Metsch
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.